Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award.
Publication
, Journal Article
Daniel, GW; Schneider, M; McClellan, MB
Published in: JAMA
September 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
ISSN
0098-7484
Publication Date
September 2017
Volume
318
Issue
12
Start / End Page
1103 / 1104
Related Subject Headings
- Value-Based Health Insurance
- United States
- Risk Sharing, Financial
- Humans
- General & Internal Medicine
- Drug Resistance, Microbial
- Drug Discovery
- Anti-Infective Agents
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Daniel, G. W., Schneider, M., & McClellan, M. B. (2017). Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award. JAMA, 318(12), 1103–1104. https://doi.org/10.1001/jama.2017.10164
Daniel, Gregory W., Monika Schneider, and Mark B. McClellan. “Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award.” JAMA 318, no. 12 (September 2017): 1103–4. https://doi.org/10.1001/jama.2017.10164.
Daniel GW, Schneider M, McClellan MB. Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award. JAMA. 2017 Sep;318(12):1103–4.
Daniel, Gregory W., et al. “Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award.” JAMA, vol. 318, no. 12, Sept. 2017, pp. 1103–04. Epmc, doi:10.1001/jama.2017.10164.
Daniel GW, Schneider M, McClellan MB. Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award. JAMA. 2017 Sep;318(12):1103–1104.
Published In
JAMA
DOI
EISSN
1538-3598
ISSN
0098-7484
Publication Date
September 2017
Volume
318
Issue
12
Start / End Page
1103 / 1104
Related Subject Headings
- Value-Based Health Insurance
- United States
- Risk Sharing, Financial
- Humans
- General & Internal Medicine
- Drug Resistance, Microbial
- Drug Discovery
- Anti-Infective Agents
- 42 Health sciences
- 32 Biomedical and clinical sciences